December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Mohammad Jad Moussa: Combining ICIs with Antiangiogenic Agents in Advanced Urothelial Cancer
Dec 22, 2024, 11:44

Mohammad Jad Moussa: Combining ICIs with Antiangiogenic Agents in Advanced Urothelial Cancer

Mohammad Jad Moussa, Oncology Fellow at MD Anderson Cancer Center, shared a post on X:

“Now in Bladder Cancer Journal of Bladder Cancer Advocacy Network.

Can Combining ICIs with Antiangiogenic Agents Revive Antiangiogenic Therapy in Advanced Urothelial Cancer?

1st Meta-Analysis: ORR 34% in ICI-naïve group vs 16% in ICI-exposed.

Better patient selection.”

Antiangiogenic therapy combined with immune checkpoint blockade in urothelial cancer: Systematic review and meta-analysis

Authors: Mohammad Jad Moussa, Iuliia Kovalenko, Emanuele Crupi, Ekaterina Proskuriakova, Yimin Geng, Giuseppe Fallara, Raed Benkhadra, Daniele Raggi, Matthew T. Campbell, Pavlos Msaouel, Omar Alhalabi

Mohammad Jad Moussa